Cargando…

Nivolumab treatment followed by atezolizumab induced encephalitis and neuropathy with antiganglioside antibodies

Detalles Bibliográficos
Autores principales:	Watanabe, Shohei, Yoshizumi, Kazuki, Moriguchi, Sayaka, Higashiyama, Tomoki, Negi, Yoshiki, Mikami, Koji, Kimura, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649576/ https://www.ncbi.nlm.nih.gov/pubmed/34926841 http://dx.doi.org/10.1016/j.ensci.2021.100386

Ejemplares similares

Autoimmune Peripheral Neuropathies and Contribution of Antiganglioside/Sulphatide Autoantibody Testing
por: Roggenbuck, Dirk, et al.
Publicado: (2020)

Investigation on antigangliosides antibodies in asymptomatic HIV patients
por: Nicolae, Ilinca, et al.
Publicado: (2014)

Antiganglioside antibodies and paraneoplastic neuromuscular junction disorder?
por: Jazebi, Noushin, et al.
Publicado: (2020)

Antiganglioside Antibodies and Inflammatory Response in Cutaneous Melanoma
por: Ene, Corina Daniela, et al.
Publicado: (2020)

Physiology of gangliosides and the role of antiganglioside antibodies in human diseases
por: Cutillo, Gianni, et al.
Publicado: (2020)

No evidence of a link between influenza vaccines and Guillain–Barre syndrome–associated antiganglioside antibodies
por: Wang, David J., et al.
Publicado: (2011)

Successful Treatment of Pulmonary Pleomorphic Carcinoma with Nivolumab: A Case Report
por: Fujimoto, Eriko, et al.
Publicado: (2018)

Aging in man. Linear increase of a novel T cell subset defined by antiganglioside monoclonal antibody 3G5
Publicado: (1987)

Atezolizumab-induced encephalitis in metastatic lung cancer: a case report and literature review
por: Arakawa, Masafumi, et al.
Publicado: (2018)

Atezolizumab-associated encephalitis in metastatic lung adenocarcinoma: a case report
por: Yamaguchi, Yoshitaka, et al.
Publicado: (2020)

Atezolizumab/bevacizumab: Severe encephalitis and immune-mediated polyradiculoneuropathy: case report
Publicado: (2021)

Atezolizumab-associated encephalitis in metastatic breast cancer: A case report
por: Chen, Guixian, et al.
Publicado: (2022)

Atezolizumab-related encephalitis in the intensive care unit: Case report and review of the literature
por: Laserna, Andrés, et al.
Publicado: (2018)

Ramsay-Hunt syndrome and subsequent sensory neuropathy as potential immune-related adverse events of nivolumab: a case report
por: Sakoh, Takashi, et al.
Publicado: (2019)

Comparative Effectiveness of Atezolizumab, Nivolumab, and Docetaxel in Patients With Previously Treated Non–Small Cell Lung Cancer
por: Ramagopalan, Sreeram, et al.
Publicado: (2021)

Atezolizumab and bevacizumab-induced encephalitis in advanced hepatocellular carcinoma: Case report and literature review
por: Özdirik, Burcin, et al.
Publicado: (2021)

Nivolumab-Induced Autoimmune Encephalitis in Two Patients with Lung Adenocarcinoma
por: Shah, Suma, et al.
Publicado: (2018)

A Case Report of Steroid Responsive Nivolumab-Induced Encephalitis
por: Richard, Kaja, et al.
Publicado: (2017)

Real-World Analysis of Nivolumab and Atezolizumab Efficacy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer
por: Alonso-García, Miriam, et al.
Publicado: (2022)

Atezolizumab-induced Encephalitis in a Patient with Hepatocellular Carcinoma: A Case Report and Literature Review
por: Satake, Tomoyuki, et al.
Publicado: (2022)

Additional Steroid Therapy for Delayed Facial Palsy in Miller Fisher Syndrome
por: Watanabe, Shohei, et al.
Publicado: (2022)

Nivolumab-Induced Encephalitis in Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome
por: Chaucer, Benjamin, et al.
Publicado: (2018)

Immune Checkpoint Inhibitor-Induced Limbic Encephalitis during Treatment with Atezolizumab in a Patient with Small-Cell Lung Cancer: A Case Report and Review of the Literature
por: Nakashima, Koki, et al.
Publicado: (2022)

Effectiveness and Cost-Effectiveness Profile of Second-Line Treatments with Nivolumab, Pembrolizumab and Atezolizumab in Patients with Advanced Non-Small Cell Lung Cancer
por: Franchi, Matteo, et al.
Publicado: (2022)

Real-World Outcomes of Nivolumab, Pembrolizumab, and Atezolizumab Treatment Efficacy in Korean Veterans with Stage IV Non-Small-Cell Lung Cancer
por: Ham, Ahrong, et al.
Publicado: (2023)

Hepatocellular carcinoma with gastric adenocarcinoma treated with atezolizumab and bevacizumab
por: Suga, Takayoshi, et al.
Publicado: (2023)

Development of Fulminant Type 1 Diabetes Mellitus in the Course of Treatment with Atezolizumab for Hepatocellular Carcinoma
por: Ikeda, Munehiro, et al.
Publicado: (2022)

Comparison of the prognostic effect of sarcopenia on atezolizumab plus bevacizumab and lenvatinib therapy in hepatocellular carcinoma patients
por: Toshida, Katsuya, et al.
Publicado: (2022)

A Case Report on Dengue Encephalitis With Optic Neuropathy
por: Khan, Nawal, et al.
Publicado: (2020)

Nivolumab or Atezolizumab in the Second-Line Treatment of Advanced Non-Small Cell Lung Cancer? A Prognostic Index Based on Data from Daily Practice
por: Knetki-Wróblewska, Magdalena, et al.
Publicado: (2023)

Atezolizumab-Induced Aseptic Meningitis in Patients with NSCLC
por: Toyozawa, Ryo, et al.
Publicado: (2020)

Intrathecal synthesis of anti-Hu antibodies distinguishes patients with paraneoplastic peripheral neuropathy and encephalitis
por: Schwenkenbecher, Philipp, et al.
Publicado: (2016)

Nivolumab-induced interstitial lung disease in a patient with gastric cancer
por: Kimura, Akie, et al.
Publicado: (2019)

PD-L1 detection using (89)Zr-atezolizumab immuno-PET in renal cell carcinoma tumorgrafts from a patient with favorable nivolumab response
por: Vento, Joseph, et al.
Publicado: (2019)

A case of nearly complete response in hepatocellular carcinoma with disseminated lung metastasis by combination therapy of nivolumab and ipilimumab after treatment failure of atezolizumab plus bevacizumab
por: Kim, Hyung Jun, et al.
Publicado: (2023)

Successful Re-administration of Atezolizumab for a Non-small-cell Lung Cancer Patient after Cardiac Tamponade Development as a Manifestation of Pseudo-progression Induced by Combination Treatment with Atezolizumab and Cytotoxic Chemotherapy
por: Nakashima, Koki, et al.
Publicado: (2021)

Case Report: Atezolizumab plus bevacizumab for combined hepatocellular-cholangiocarcinoma
por: Satake, Tomoyuki, et al.
Publicado: (2023)

Severe Demyelinating Neuropathy in an Advanced Melanoma Patient Treated with Nivolumab plus Ipilimumab Combined Therapy
por: Kambayashi, Yumi, et al.
Publicado: (2020)

Atezolizumab plus bevacizumab versus sorafenib or atezolizumab alone for unresectable hepatocellular carcinoma: A systematic review
por: Ahmed, Faiza, et al.
Publicado: (2021)

Comparison of atezolizumab, durvalumab, pembrolizumab, and nivolumab as first-line treatment in patients with extensive-stage small cell lung cancer: A systematic review and network meta-analysis
por: Chen, Jianxin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ehm47utfg5ha6an582v0o7u0vg